DoctorJulie Campbell

Senior Research Fellow

Menzies Institute for Medical Research

  • Senior Research Fellow
    Menzies Institute for Medical Research

RESEARCH SUMMARy

Expertise:
Economic evaluation 

Cost of illness
Health economics
Neurological economics
Medical economics
Energy economics
Behavioural economics
Labour economics
Health systems and health services research
Cost and cost analysis
Patient reported outcome measures (PROMs)
Qualitative research in health economics
Quality of life research
Wellbeing
Clinical trials and observational studies
Survey design
Multi-attribute utility instruments and health state utilities
Neurological conditions

Multiple Sclerosis 
Obesity
Long Covid
Cardiovascular conditions
Diabetes
Multimorbidity
Collaboration: Julie is currently involved in several local, national and international projects regarding the health economics of complex and chronic disease, streamlined models of care for improved health services delivery and quality of life research.

FUNDED PROJECTS

  • GRANT
    Implementing improved blood pressure measurement in general practice
    1 Sep 2026 - 30 Sep 2030
    People funded by this grant:
    • Sharman J,
    • Schutte A,
    • Nelson M,
    • Gall S,
    • Schlaich M
    Project Total: $1,128,106; High blood pressure (BP) is the single largest modifiable risk factor accounting for the greatest burden of death and disability from cardiovascular disease (CVD) in Australia. Accurate BP measurement is essential so that correct hypertension diagnosis and clinical care can be provided to lower risk for future CVD events (i.e. strokes, heart attacks). Most hypertension is managed in general practice, but it is not feasible for general practitioners (GPs) to perform standardised and accurate BP measurement in this setting, mainly due to time contraints. The result is that GPs do not trust the BP values and this leads to therapeutic inertia and increases in avoidable strokes and heart attacks. This project addresses this problem by implementing an intervention to accurately measure BP by using automated office BP (AOBP) in a process that has been co-designed with GPs, other health care professionals and community. AOBP is a standardised, automated procedure that is undertaken by a trained person in a quiet area outside of the GP examination room prior to consultation. This method is already recommended by guidelines and desired by GPs but not currently used because of barriers faced by GPs, including lack of access to equipment, education and training to measure and interpret AOBP. All these resources will be provided in this project in which AOBP intervention will be implemented in general practice clinics across Australia. It is expected that the AOBP intervention will be associated with significantly increased proportion of patients with treated and controlled hypertension. The project will also determine the essential elements for sustainable adoption of AOBP in general practice according to established implementation science frameworks. Ultimately, the project will provide a high-quality system of care resulting in improved BP measurement, better BP control, lower risk for adverse CVD events, and major health cost savings in Australia. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($2,256,211); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis (PLATYPUS)
    8 Jul 2026 - 15 Mar 2030
    People funded by this grant:
    • Taylor B,
    • Foong YC,
    • Stevens N,
    • Ng YZJ,
    • Young K
    Project Total: $95,220; A multicentre, interventional, multi-arm, multi-stage trial including randomisation, double blinding, placebo control evaluation of treatments for slowing the progression of disability in participants with Secondary Progressive Multiple Sclerosis (SPMS) and Primary Progressive Multiple Sclerosis (PPMS), together termed Progressive Multiple Sclerosis (PMS). Funded by: Multiple Sclerosis Australia; Griffith University; MSWA; University of Tasmania.
  • GRANT
    The double burden of wage discrimination for marginalised groups with MS
    1 Jan 2025 - 30 Jun 2026
    People funded by this grant:
    • Campbell J,
    • van der Mei I,
    • Taylor B,
    • Kamal M,
    • Blacklow P
    Project Total: $24,833; Employment provides substantial socioeconomic benefits to an individual by granting access to economic resources, fostering social networks, offering opportunities to develop life skills, and promoting a sense of self-worth. There is a positive association between employment, quality of life and life satisfaction for people living with disability. The health economic impact of MS is high costing Australian society over $2.5 billion per year. There are also significant quality of life impacts for families, carers and supporters. As MS-related disability severity increases the health and economic burden of MS increases significantly. To illustrate, as disability severity increases from no to severe MS-related disability, the cost to Australian society is 270% higher ($32,000 to $125,000 per year per person living with MS) Importantly, these estimates are likely underestimates. There are many inputs to the economic equation that need to be explored including the level of wage discrimination for people living with MS in Australia and how this wage discrimination is likely increased as disability severity increases for people who remain in the workforce (particularly as people transition from no to mild and moderate disability). A notable characteristic of MS is its disproportionate effect on women, with a female-to-male prevalence ratio reaching as high as 3:1. The existing literature has shown that gender discrimination continues to exist in the labour market in various stages, from recruitment to promotion. Previous work has also shown that women face a double burden in the labour market in the presence of intersectionality of gender and disability or other health-related problems. This is also revealed for people who identify as non-binary. Therefore, we aim to evaluate if the association between living with MS and income differs according to gender in Australia and if labour market discrimination can be identified as a potential source for such outcomes. Funded by: Multiple Sclerosis Australia - Grant-Incubator ($24,833); University of Tasmania.
  • GRANT
    Counting what counts: using a national cohort study to develop, validate and apply an Indigenous Quality of Wellbeing Utility Index and quantifying key determinants of health
    1 Jul 2024 - 30 Jun 2029
    People funded by this grant:
    • Lovett R,
    • de Graaff B,
    • Campbell J,
    • Thurber K,
    • Brown A
    Project Total: $1,789,516; This collaborative project aims to develop and validate an Indigenous-specific health state utility instrument. Currently, no utility instruments exist that can be applied in health economic evaluations that relate to Aboriginal and Torres Strait Islander peoples wellbeing. Current instruments have been developed based on Western concepts of wellbeing, and do not capture important aspects such as culture, spirituality, and Country. This study will develop the Indigenous Quality of Wellbeing utility instrument, validate this and apply it in a nested longitudinal study to generate health state utility values for a large cohort of Aboriginal and Torres Strait Islander people. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Clinical Trial and Cohort Studies; Australian National University; University of Tasmania.
  • GRANT
    Investigating the double burden of wage discrimination for women and marginalised groups living with Multiple Sclerosis
    13 Jun 2024 - 31 Dec 2024
    People funded by this grant:
    • Campbell J,
    • Kamal M,
    • van der Mei I,
    • Taylor B,
    • Blacklow P
    Project Total: $27,500; MS costs Australia over $2.5Billion per year, however, this is likely an underestimate. There are many inputs to the economic equation that need to be explored including the level of wage discrimination for people living with MS in Australia, particularly women and marginalised groups, and how this wage discrimination is likely increased as disability severity increases for people who remain in the workforce (particularly for people who transition from no, to mild and moderate disability). Overall, we aim to evaluate if the association between multiple sclerosis and earnings (including income) differs from a wage discrimination perspective according to gender in Australia. We hypothesise that there is a double burden, especially as MS-related disability increases. Funded by: Donation via Menzies Institute for Medical Research - Donation ($27,500); University of Tasmania.
  • GRANT
    A phase III, multicentre, randomised, double-blinded, placebo-controlled clinical trial of SpironolacTOne and famciclovir in Progressive Multiple Sclerosis: the STOP-MS trial
    1 Jan 2024 - 31 Dec 2028
    People funded by this grant:
    • Broadley S,
    • Taylor B,
    • Young K,
    • Campbell J,
    • Barnett M
    Project Total: $1,999,363; The Epstein-Barr virus that causes glandular fever has recently been identified as the likely primary cause of multiple sclerosis. Progressive forms of multiple sclerosis can have significant impact on quality of life and are currently hard to treat. We have selected two potential anti-EBV therapies (spironolactone and famciclovir) to test in an innovative multi-stage, multi-arm trial in order to identify the best treatment for progressive MS. Treatments will be compared to dummy-treatment. Funded by: Medical Research Future Fund - Grant - Multiple Sclerosis Research; Griffith University; University of Tasmania.
  • GRANT
    Applying modern health economics methods to Multiple Sclerosis: Estimating societal burden and impact of interventions to guide scarce resource allocation
    1 Jan 2024 - 31 Dec 2026
    People funded by this grant:
    • Campbell J
    Project Total: $225,000; My vision is to adopt modern health economics thinking and methods regarding novel elements of value to the chronic neurological illness MS in order to: 1) estimate the broader societal economic burden of MS; 2) assess the health economic impact of interventions/programs/systems; and 3) contribute to development of digital health economic tools that can be used by policy makers for MS and other chronic disease. Funded by: Multiple Sclerosis Australia - Fellowship-Postdoctoral ($225,000); University of Tasmania ($280,311).
  • GRANT
    The effect of interdisciplinary lifestyle management for weight loss
    1 Jan 2024 - 31 Dec 2026
    People funded by this grant:
    • Probst Y,
    • Campbell J
    Project Total: $250,000; A randomised control trial for the interdisciplinary management of weight loss for people living with MS Funded by: Multiple Sclerosis Australia - Grant-Project; University of Wollongong; University of Tasmania.
  • GRANT
    Understanding patient preferences for delivery of oral and non-oral medications across and within acute and chronic conditions: a systematic literature review
    28 Sep 2023 - 28 Feb 2025
    People funded by this grant:
    • Roydhouse J,
    • Campbell J
    Project Total: $116,006; The overall goal of this project is to summarise patient preferences for the mode and frequency of drug administration, enabling key stakeholders to understand these preferences across conditions and settings. Funded by: Pfizer Inc - Grant ($116,006); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Economic Impact report 2023
    1 Jan 2023 - 31 Dec 2025
    People funded by this grant:
    • van der Mei I,
    • Palmer A,
    • Campbell J,
    • Taylor B,
    • Zhao T
    Project Total: $184,175; To produce a Report on the Economic Impact of MS in Australia in that: A brief overview of MS Prevalence of MS Healthcare costs and indirect costs (including lost productivity) Quality of life for those affected by MS Funded by: Multiple Sclerosis Australia ($184,175); University of Tasmania.
  • GRANT
    Evaluating the factors influencing National Disability Insurance Scheme participation and its impact among Australians with MS
    1 Jan 2023 - 31 Dec 2025
    People funded by this grant:
    • Taylor B,
    • Claflin S,
    • van der Mei I,
    • Lechner-Scott J,
    • Campbell J
    Project Total: $244,123; This project will evaluate the roll out of the National Disability Insurance Scheme (NDIS) among Australian living with MS. We will investigate factors associated with NDIS participation and, among participants, NDIS plan value. In order to do this, we will conduct a several studies, including a retrospective cohort study in a representative group of Australians living with MS. Funded by: Multiple Sclerosis Australia - Grant-Project ($244,123); University of Tasmania.
  • GRANT
    Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence
    1 Jan 2022 - 31 Dec 2026
    People funded by this grant:
    • de Graaff B,
    • Cowie B,
    • Campbell J,
    • Wills K,
    • Stephens N
    Project Total: $750,738; Chronic hepatitis B (CHB) is endemic across Indigenous communities in the Northern Territory (NT), with prevalence between 2-5%. Of this group, up to 25% will die from decompensated cirrhosis or liver cancer without care and treatment. In turn, liver disease is the third leading factor contributing to the gap in life expectancy between Indigenous and non-Indigenous Australians. In 2017 the NHMRC funded the Hep B PAST Partnership Project (GNT1151837), which aims to eliminate CHB from NT Indigenous Australians. This is being achieved through two mechanisms: improvement of CHB health literacy amongst participating Indigenous communities and healthcare providers; and transition of CHB care to a primary healthcare based, co-ordinated chronic disease model supported by the establishment of a CHB clinical register. The preliminary results of the Hep B PAST Project have demonstrated a highly effective model of care to increase rates of CHB diagnosis, treatment and community education. The Hep B PAST Project will be completed in mid-2023. To successfully eliminate hepatitis B, it is now critically important to transition this care model Territory-wide. Health economic evidence is now required by government to support this. We have developed five studies to generate this evidence: 1: Quantify costs of the Hep B PAST model of care and the status quo approach to CHB care; 2: Quantify quality of life/health state utility values for hepatitis B health states; 3. Develop and validate a health economic disease simulation model for hepatitis B for Indigenous communities; 4: Project clinical outcomes of the Hep B PAST model of care and the status quo up to 2035; 5: Assess the cost-effectiveness of introducing the Hep B PAST model of care as standard practice across the NT. We will develop the first Indigenous-specific health economic model that will be made available to support rapid, robust evaluations to introduce Hep B PAST into other states/territories. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,501,476); University of Tasmania.
  • GRANT
    Hospital Acquired Complications: prevalence and economic implications
    1 Jan 2022 - 31 Dec 2023
    People funded by this grant:
    • de Graaff B,
    • Hensher M,
    • Campbell J,
    • Otahal P
    Project Total: $61,214; The first principle of health care is to do no harm. Yet approximately 1 in 10 patients continue to experience harmful safety lapses during their care (Slawomirski & Klazinga 2022). In the hospital setting, these adverse events -- also called hospital-acquired complications (HACs) -- include nosocomial infections, inpatient falls, venous thromboembolism and pressure injuries. Not every HAC is preventable, but their incidence can be reduced through clinical risk management strategies, protocols and interventions. These can be highly cost-effective, especially if implemented within a complementary policy and funding framework (Slawomirski & Klazinga 2022). The Australian Commission on Safety and Quality in Health Care has listed 16 priority HACs that are common and amenable to reduction. The use of the condition onset flag (COF) in Australian admitted patient data makes it possible to determine if a diagnosis was pre-existing or of it was acquired during the episode of care. While some HACs result in premature death, most increase patient morbidity prolonging length of stay and requiring additional medical and surgical interventions. The cost of this additional care in Australia and other developed countries is estimated at 10% to 15% of hospital expenditure (Ehsani et al 2006; Slawomirski et al 2017). In 2018, the Independent Hospital Pricing Authority (IHPA) introduced a national pricing adjustment scheme where the incremental cost of the ACSQHCs sixteen priority HACs is not funded. However, the additional health needs of harmed patients rarely end at hospital discharge. Many HACs will necessitate more follow-up treatment in outpatient, primary and community care, emergency presentations and even hospital readmissions. Relatively little empirical work has been conducted on these downstream effects and their resulting costs of hospital harm. Also, while frailty, co-morbidities, polypharmacy and length of stay are known to increase likelihood of harm, there may be other patient-related or contextual factors that can be used to manage risk. In addition, the association between patient harm and the emerging field of low-value care has not been studied extensively. Funded by: Donation via Menzies Institute for Medical Research - Donation ($61,214); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Prevalence and economic cost of multiple sclerosis in Australia 2022
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Palmer A,
    • Campbell J
    Project Total: $20,000; A quick update of prevalence and costs of MS in 2022, at the request of MS Australia who contacted me a couple of days ago with money to spend before the EOFY. We will: A) Use the methods described in Palmer et al1 and Campbell et al2 to give an updated estimate of the 2021/22 prevalence of MS B) Use inflation rates to update the total costs from the Health Economic Impact of Multiple Sclerosis in Australia 2017? report to 2021/22 values C) Provide a preliminary written report of not less than 5 pages, including an executive summary, that details the methods used and the results of A and B. D) Included one round of revisions following review by MS Australia of preliminary report E) Deliver final report in electronic form Budget: $20,000 Timelines: Work to commence July 1, 2022 Preliminary report delivered to MS Australia by September 15th Revisions to be provided by MS Australia by end September 2022 Final report delivered by October 15, 2022. Funded by: Multiple Sclerosis Australia ($20,000); University of Tasmania.
  • GRANT
    The health economic impacts of residential fires on the Tasmanian public healthcare system 2010 to 2020 using a mixed-methods approach
    1 Jan 2022 - 30 Sep 2025
    People funded by this grant:
    • Dinh TTN,
    • Campbell J,
    • Palmer A,
    • Schrale R,
    • Ratcliffe K
    Project Total: $9,945; This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,945); University of Tasmania.
  • GRANT
    A new model of shared care across Geriatric Medicine and General Surgery for older Tasmanians.
    1 Jan 2021 - 31 Dec 2021
    People funded by this grant:
    • Evans T,
    • Ferrah N,
    • Turner R,
    • Jose M,
    • Britcliffe A
    Project Total: $25,000; Older Tasmanians undergoing emergency surgery are at high risk of complications and of subsequently needing rehabilitation or nursing home placement following discharge. We will investigate the need for a novel model of shared Geriatric/General Surgery care for older RHH patients, and measure its effect on return to pre-admission residence and in-hospital complications. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project; University of Tasmania.
  • GRANT
    Cognitive Behaviour Therapy and Mindfulness Group Intervention for Tasmanian Women Living with Persistent Pelvic Pain.
    1 Jan 2021 - 31 Dec 2022
    People funded by this grant:
    • Van Niekerk L,
    • Matthewson M,
    • Aitken D,
    • Campbell J,
    • Ramsden C
    Project Total: $9,966; The physical, psychological, personal, financial and occupational burden experienced by women diagnosed with persistent pelvic pain (PPP) is significant. Tasmanian women face additional barriers to accessing treatment due to a lack of available services. This project will reduce this burden by providing evidence-based group psychological therapy for Tasmanian women living with persistent pelvic pain (PPP). Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,966); University of Tasmania.
  • GRANT
    Patient and carer experiences with relapsed/refractory multiple myeloma and myelodysplastic syndrome
    1 Jan 2021 - 31 Mar 2023
    People funded by this grant:
    • Roydhouse J,
    • Harrup R,
    • Nicholson L,
    • Thompson D,
    • Campbell J
    Project Total: $18,017; The project aims to assess the experience of patients with chronic haematologic malignancies, specifically relapsed/refractory multiple myeloma (RRMM) and myelodysplastic syndrome (MDS) and their carers. Although these conditions are treatable, they are not curable and the treatments can impose significant side effects. As they are incurable, patient quality of life and symptom burden and management are important concerns. This study will help us understand the patient experience in these areas, thereby leading to appropriate interventions and potentially better care. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($18,017); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Prevalence, incidence, risk profiles, and health impacts of residential fires in Tasmania 2010-2020
    1 Jan 2021 - 31 May 2023
    People funded by this grant:
    • Campbell J,
    • Palmer A,
    • de Graaff B
    Project Total: $30,000; This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020. Funded by: Tasmania Fire Service ($30,000); University of Tasmania ($1,981).
  • GRANT
    Using data linkage to estimate the burden of diabetes in Tasmania
    1 Jan 2021 - 13 Dec 2021
    People funded by this grant:
    • Palmer A,
    • Jose M,
    • de Graaff B,
    • Campbell J
    Project Total: $24,969; Using pathology, hospital, emergency department, and mortality data linked from four different datasets in Tasmania, this project will quantify the health economic burden associated with diabetes for the Tasmanian Health System, and identifying potential factors that may be targeted for improved patient outcomes and/or cost savings to government. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,969); University of Tasmania.
  • GRANT
    Understanding the economic burden of climate-related extreme events: A framework to support future planning and decision making in the health care sector
    19 Oct 2020 - 18 Oct 2021
    People funded by this grant:
    • Johnston F,
    • Palmer A,
    • Campbell S,
    • Campbell J,
    • Remenyi T
    Project Total: $57,528; This project blends climate change projection data with health economics to estimate the future health and economic impact of climate-related extreme events in Tasmania. By building on our team's previous research examining the historical impact of heatwaves on Tasmania's health system, this research provides a foundation for policy development and health system planning. Importantly, in addition to specific information on heatwave impacts, this research will provide a generalisable framework to allow the health economic impact of climate change to be estimated for other climate-related natural disasters and compound extreme events. This information can be used by health care services both in Tasmania and across other jurisdictions. Funded by: Department of Premier and Cabinet - Climate Research Grants Program ($49,528); Department of Health and Human Services Tasmania ($8,000); University of Tasmania.
  • GRANT
    Economic impact of MS: creating independent standards for health economic evaluation of MS interventions aimed to prevent MS or halt disease severity
    1 Jan 2020 - 30 Jun 2023
    People funded by this grant:
    • Campbell J
    Project Total: $210,000; This Postdoctoral Fellowship application is a comprehensive and integrated 3-year work program that aims to create and develop the word's first suite of objective and validated tools for the health economic evaluation of multiple sclerosis. Funded by: Multiple Sclerosis Australia - Fellowship-Postdoctoral ($210,000); University of Tasmania.
  • GRANT
    NAFLD- screen (Non-alcoholic fatty liver disease: prevalence and screening for type 2 diabetes patients)
    1 Jan 2020 - 31 Dec 2022
    People funded by this grant:
    • de Graaff B,
    • Yee K,
    • Campbell J,
    • Palmer A,
    • Lartey S
    Project Total: $24,999; This study will assess the prevalence of non-alcohol fatty liver disease (NAFLD) in patients with type 2 diabetes and normal liver function tests attending the Royal Hobart Hospital Diabetes Outpatient Clinic. It will further assess the most cost-effective strategy for targeted screening for this patient group. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,999); University of Tasmania.
  • GRANT
    ANCHOR Project: heAlth ecoNomics and epidemiology of myalgiC encephalomyelitis/ chronic fatigue syndrome
    1 Jul 2019 - 31 Dec 2022
    People funded by this grant:
    • de Graaff B,
    • Campbell J,
    • Nicholl H,
    • Hensher M,
    • Wills K
    Project Total: $155,000; Funded by: Medical Research Future Fund - Grant - Targeted Health System and Community ($155,000); University of Tasmania.
  • GRANT
    Evaluation of the Tasmanian Elective Surgery Panel Project
    1 Jan 2019 - 31 Dec 2020
    People funded by this grant:
    • de Graaff B,
    • Song J,
    • Hensher M,
    • Campbell J,
    • Glading J
    Project Total: $9,980; In 2015, the Tasmanian State Government allocated additional funds to reduce the public hospital elective surgery waiting lists. A subset of waitlisted patients was 'fast-tracked' for elective surgery to hospitals in Tasmania and Victoria. This project will evaluate the outcomes of this initiative. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,980); University of Tasmania.